—#131283

Product

Aquapak Adaptor, 028 NEB, INTL, Product No. 403128; Aquapak Adaptor, 033 NEB, INTL, Product No. 403133; Aqaupak Nebulizer Adaptor 028, Sterile, Shelfpak, Product No. 031-28 & 031-28F, Aqaupak Nebulizer Adaptor 033, Sterile, Shelfpak, Product No. 031-33; Aqaupak Nebulizer Adaptor 033, Sterile, Japanese, Product No. 031-33J. Used in anesthesiology.

FDA product code: CAF — Nebulizer (Direct Patient Interface)
Device class: Class 2
Medical specialty: Anesthesiology
Affected lot / code info: Product No. 043128, Lot # 02E1200719, 02E1200720, 02E1201281, 02F1200964, 02K1201946, 02E1201808, 02E1203097, 02G1300256, 02G1301048, & 02M1201691; Product No. 403133, Lot # 02E1201282, 02K1201948, 02F1200965, 02L1201194, 02M1200230, & 02F1302063; Product No. 031-28, Lot # 02D1202234, 02A1202383, 02A1202382, 02B1201069, 02D1200247, 02D1200248, 02D1201944, 02D1202274, 02D1202733, 02D1202236, 02D1202734, 02D1202735, 02D1202233, 02G1200664, 02G1200678, 02G1201016, 02G1201698, 02F1200961, 02G1200676, 02M1200585, 02L1200927, 02M1200749, 02M1201693, 02A1300194, 02A1300457, 02D1301655, 02D1301191, 02D1300864, 02D1301192, 02D1302730, 02F1301742, 02E1302765, 02F1300739, 02F1302062, & 02D1200249; Product No. 031-28F, Lot # 02E1200717, 02K1201947, 02F1200962, & 02E1202197; Product No. 031-33, Lot # 02E1200718, 02A1202384, 02E1202198, 02F1200963, 02G1200666, 02J1202240, 02M1200584, 02M1200748, 02M1201771, 02D1302731, 02A1300458, 02B1300718, & 02M1201692; Product No. 031-33J, Lot # 02D1202258, 02D1202260, 02D1202259, 02D1202261, 02E1201563, 02E1201279, 02E1203866, 02M1200747, 02B1300717, 02B1301203, 02E1301554, 02B120342, 02J1201473, 02J1202736, 02F1201179, & 02M1200057.

Why it was recalled

Possibility that the nebulizer adaptor packaging may have open or weak seals which may affect the sterility of the adaptor.

Root cause (FDA determination)

Packaging change control

Action the firm took

Customers were notified of the recall by letter on September 3, 2014. The letter requested that they discontinue distribution and quarantine the products and return the products to Teleflex. The letter also requested a sub-recall.

Recalling firm

Firm: Teleflex Medical
Address: 4024 Stirrup Creek Dr, Durham, North Carolina 27703-9000

Distribution

Distribution pattern: Worldwide Distribution-US (nationwide) including Puerto Rico and the states of AL, AK, AZ, AR, CA, CO, CT, FL, GA, HI, ID, IL, IN, IA, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, MT, NE, NV, NH, NJ, NM, NY, NC, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, WA, WV, WI, WY, and the countries of United Arab Emirates, Australia, Belgium, Brazil, Canada, Chile, China, France, Great Britain, Japan, India, Indonesia, Israel, South Korea, Mexico, Philippines, Saudi Arabia, Singapore, Taiwan, Thailand, Uruguay, and Zambia.

Timeline

Recall initiated: 2014-09-03
Posted by FDA: 2014-12-12
Terminated: 2017-08-14
Status: —

Source: openFDA Device Recall endpoint. Recall record ID #131283. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.